Global demand for rapid diagnostics continues to accelerate as the U.S. market is forecast to reach USD 7.10 Billion by 2035 and Europe USD 6.36 Billion, supported by expanding home testing, clinical ...

Two Ebola drugs are due to be trialled in the Democratic Republic of Congo (DRC) as cases of the disease continue to rise in ...

A life sciences firm has launched a development drive to tackle Ebola. Aptamer Group is working on an antibody alternative to ...

Aptamer Group (LSE:APTA) has begun a new development programme to create Optimer binders for a rapid diagnostic test targeting the Bundibugyo strain of the Ebola virus, following the largest recorded ...

A survey has found six in 10 over-65s are already worrying about catching the flu or COVID-19 when visiting A&E this winter.

The test uses the same technology found in Covid tests, and simply requires a single semen sample.

Edge-stitched MOF membranes improve water purification by reinforcing weak seams while preserving PFAS rejection, water flow, ...

Rapid Medical Diagnostic Kits Market growth is supported by strong adoption across North America, which accounted for 37% of ...

Helping More People Know Their HIV Status National HIV Testing Day highlights the importance of knowing one's HIV status and connecting with ...

York-based Aptamer Group PLC company has started work on developing a diagnostic test for a highly infectious strain of the ...

K92 Mining Inc. (“K92 ” or the “Company ”) (TSX: KNT; OTCQX: KNTNF) is pleased to announce production results for the second ...

The sector's future increasingly depends on research, innovation and the adoption of modern technologies capable of boosting productivity while safeguarding crops against emerging threats. Recognising ...